SCHEMBL4551630

SCHEMBL4551630

COc1ccc(C(C)(C)C)cc1Nc1ccc(C)c(-c2cc(CNC(=O)c3ccccn3)on2)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 7/20 0.43
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
KCNH2 Q12809 1/20 0.39
GRIN2B Q13224 1/20 0.39
HDAC6 Q9UBN7 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
FLT3 P36888 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
KDR P35968 1/20 0.36
TEK Q02763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4551631 0.89 GRM4 (0.49) GRM4NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL5604346 0.88 HTT (0.42) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL5602271 0.87 HTT (0.43) SMN1; SMN2TSHRHTT
SCHEMBL4407836 0.78 NR1H4 (0.45) KDM4EHTT
SCHEMBL4414236 0.76 NAMPT (0.43) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL5593328 0.76 RXFP1 (0.43) KDM4ETSHRHTT
SCHEMBL5592971 0.75 RXFP1 (0.42) SMN1; SMN2KDM4ETSHRHTT
SCHEMBL4417707 0.75 CYP3A4 (0.43) RAB9ASMN1; SMN2KDM4ETSHRHTT
SCHEMBL5616375 0.74 MAPT (0.48) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL5602261 0.74 HTT (0.43) TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed